261 studies found for:    Tocilizumab
Show Display Options
Rank Status Study
1 Completed
Has Results
An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Tocilizumab
2 Completed
Has Results
A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Tocilizumab
3 Completed
Has Results
Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine
Condition: Rheumatoid Arthritis
Intervention: Drug: Tocilizumab
4 Terminated Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Tocilizumab
5 Active, not recruiting Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
Conditions: Intermediate Uveitis;   Posterior Uveitis;   Pan-uveitis
Intervention: Drug: Tocilizumab
6 Not yet recruiting EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Tocilizumab
7 Terminated Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
Conditions: Arthritis, Juvenile Rheumatoid;   Still's Disease, Juvenile Onset
Intervention: Biological: tocilizumab
8 Withdrawn Tocilizumab for Relapsing Polychondritis
Condition: Relapsing Polychondritis
Intervention: Drug: Tocilizumab
9 Recruiting Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Tocilizumab
10 Completed
Has Results
An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Tocilizumab
11 Recruiting A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
12 Completed Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: Tocilizumab;   Drug: Methotrexate
13 Completed
Has Results
An Open-Label Trial of Tocilizumab in Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Tocilizumab
14 Terminated Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease
Condition: Erdheim-Chester Disease
Intervention: Drug: Tocilizumab
15 Completed A Long Term Extension Study of WA19926 (NCT01649804) of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Tocilizumab
16 Recruiting Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
17 Active, not recruiting Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Tocilizumab;   Drug: Placebo
18 Active, not recruiting A Study to Evaluate the Pharmacokinetic and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
19 Active, not recruiting Study of Tocilizumab to Treat Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica (PMR)
Intervention: Drug: Tocilizumab
20 Completed
Has Results
An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice
Condition: Rheumatoid Arthritis
Intervention: Biological: Tocilizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.